The fluorometric microculture cytotoxicity assay (Q39949051)

15 September 2017

The fluorometric microculture cytotoxicity assay (English)

1 reference

15 September 2017

0 references

2

Peter Nygren

1 reference

15 September 2017

3

Rolf Larsson

1 reference

15 September 2017

Elin Lindhagen

1

1 reference

15 September 2017

1 January 2008

1 reference

15 September 2017

1 reference

15 September 2017

3

1 reference

15 September 2017

8

1 reference

15 September 2017

1364-1369

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2008.114

15 September 2017

0 references

cites work

Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

The novel alkylating prodrug J1: diagnosis directed activity profile ex vivo and combination analyses in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Primary lymphocytes as predictors for species differences in cytotoxic drug sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2008.114

31 March 2020

Identifiers

DOI

10.1038/NPROT.2008.114

1 reference

PubMed ID

18714304

Dimensions Publication ID

15 September 2017

0 references

1 reference

PubMed ID

18714304